Works matching IS 03407004 AND DT 2023 AND VI 72 AND IP 8

Results: 27

Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2829, doi. 10.1007/s00262-023-03464-w
By:
- Himuro, Hidetomo;
- Nakahara, Yoshiro;
- Igarashi, Yuka;
- Kouro, Taku;
- Higashijima, Naoko;
- Matsuo, Norikazu;
- Murakami, Shuji;
- Wei, Feifei;
- Horaguchi, Shun;
- Tsuji, Kayoko;
- Mano, Yasunobu;
- Saito, Haruhiro;
- Azuma, Koichi;
- Sasada, Tetsuro
Publication type:
Article
Induction of cancer neoantigens facilitates development of clinically relevant models for the study of pancreatic cancer immunobiology.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2813, doi. 10.1007/s00262-023-03463-x
By:
- Panni, Usman Y.;
- Chen, Michael Y.;
- Zhang, Felicia;
- Cullinan, Darren R.;
- Li, Lijin;
- James, C. Alston;
- Zhang, Xiuli;
- Rogers, S.;
- Alarcon, A.;
- Baer, John M.;
- Zhang, Daoxiang;
- Gao, Feng;
- Miller, Christopher A.;
- Gong, Qingqing;
- Lim, Kian-Huat;
- DeNardo, David G.;
- Goedegebuure, S. Peter;
- Gillanders, William E.;
- Hawkins, William G.
Publication type:
Article
Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2851, doi. 10.1007/s00262-023-03462-y
By:
- Stegmann, Toon;
- Wiekmeijer, Anna-Sophia;
- Kwappenberg, Kitty;
- van Duikeren, Suzanne;
- Bhoelan, Farien;
- Bemelman, Denzel;
- Beenakker, Thomas J. M.;
- Krebber, Willem-Jan;
- Arens, Ramon;
- Melief, Cornelis J. M.
Publication type:
Article
Sequential CAR T cell and targeted alpha immunotherapy in disseminated multiple myeloma.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2841, doi. 10.1007/s00262-023-03461-z
By:
- Awuah, Dennis;
- Minnix, Megan;
- Caserta, Enrico;
- Tandoh, Theophilus;
- Adhikarla, Vikram;
- Poku, Erasmus;
- Rockne, Russell;
- Pichiorri, Flavia;
- Shively, John E.;
- Wang, Xiuli
Publication type:
Article
Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2799, doi. 10.1007/s00262-023-03460-0
By:
- Yamaki, Hidekiyo;
- Kono, Michihisa;
- Wakisaka, Risa;
- Komatsuda, Hiroki;
- Kumai, Takumi;
- Hayashi, Ryusuke;
- Sato, Ryosuke;
- Nagato, Toshihiro;
- Ohkuri, Takayuki;
- Kosaka, Akemi;
- Ohara, Kenzo;
- Kishibe, Kan;
- Takahara, Miki;
- Hayashi, Tatsuya;
- Kobayashi, Hiroya;
- Katada, Akihiro
Publication type:
Article
Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2783, doi. 10.1007/s00262-023-03459-7
By:
- Franks, S. Elizabeth;
- Santiago-Sanchez, Ginette S.;
- Fabian, Kellsye P.;
- Solocinski, Kristen;
- Chariou, Paul L.;
- Hamilton, Duane H.;
- Kowalczyk, Joshua T.;
- Padget, Michelle R.;
- Gameiro, Sofia R.;
- Schlom, Jeffrey;
- Hodge, James W.
Publication type:
Article
Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel developed from bulk mRNA sequencing and single-cell RNA-sequencing.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2757, doi. 10.1007/s00262-023-03458-8
By:
- Jang, Sung Ill;
- Lee, Hyung Keun;
- Chang, Eun-Ju;
- Kim, Somi;
- Kim, So Young;
- Hong, In Young;
- Kim, Jong Kyoung;
- Lee, Hye Sun;
- Yang, Juyeon;
- Cho, Jae Hee;
- Lee, Dong Ki
Publication type:
Article
Correction to: Increased TIGIT expressing NK cells with dysfunctional phenotype in AML patients correlated with poor prognosis.
Published in:
2023
By:
- Liu, Guanfang;
- Zhang, Qi;
- Yang, Jingying;
- Li, Xiaomin;
- Xian, Luhua;
- Li, Wenmin;
- Lin, Ting;
- Cheng, Juan;
- Lin, Qiwen;
- Xu, Xiuzhang;
- Li, Qin;
- Lin, Yu;
- Zhou, Maohua;
- Shen, Erxia
Publication type:
Correction Notice
The pathogenetic significance of exhausted T cells in a mouse model of mature B cell neoplasms.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2635, doi. 10.1007/s00262-023-03447-x
By:
- Shibamiya, Asuka;
- Miyamoto-Nagai, Yurie;
- Koide, Shuhei;
- Oshima, Motohiko;
- Rizq, Ola;
- Aoyama, Kazumasa;
- Nakajima-Takagi, Yaeko;
- Kato, Rei;
- Kayamori, Kensuke;
- Isshiki, Yusuke;
- Oshima-Hasegawa, Nagisa;
- Muto, Tomoya;
- Tsukamoto, Shokichi;
- Takeda, Yusuke;
- Koyama-Nasu, Ryo;
- Chiba, Tetsuhiro;
- Honda, Hiroaki;
- Yokote, Koutaro;
- Iwama, Atsushi;
- Sakaida, Emiko
Publication type:
Article
Single-center phase 2 study of PD-1 inhibitor combined with DNA hypomethylation agent + CAG regimen in patients with relapsed/refractory acute myeloid leukemia.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2769, doi. 10.1007/s00262-023-03454-y
By:
- Gao, Xiao-Ning;
- Su, Yong-Feng;
- Li, Meng-yue;
- Jing, Yu;
- Wang, Jun;
- Xu, Lei;
- Zhang, Lin-Lin;
- Wang, An;
- Wang, Yi-Zhi;
- Zheng, Xuan;
- Li, Yan-Fen;
- Liu, Dai-Hong
Publication type:
Article
Massively recruited sTLR9+ neutrophils in rapidly formed nodules at the site of tumor cell inoculation and their contribution to a pro-tumor microenvironment.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2671, doi. 10.1007/s00262-023-03451-1
By:
- Kou, Mengyuan;
- Lu, Wenting;
- Zhu, Mengru;
- Qu, Kuo;
- Wang, Liying;
- Yu, Yongli
Publication type:
Article
Characterizing the tumor immune microenvironment of ependymomas using targeted gene expression profiles and RNA sequencing.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2659, doi. 10.1007/s00262-023-03450-2
By:
- de Koning, W.;
- Feenstra, F. F.;
- Calkoen, F. G. J.;
- van der Lugt, J.;
- Kester, L. A.;
- Mustafa, D. A. M.
Publication type:
Article
Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2649, doi. 10.1007/s00262-023-03449-9
By:
- Toulemonde, E.;
- Chevret, S.;
- Battistella, M.;
- Neidhardt, E. M.;
- Nardin, C.;
- Le Du, F.;
- Meyer, N.;
- Véron, M.;
- Gambotti, L.;
- Lamrani-Ghaouti, A.;
- Jamme, P.;
- Chaffaut, C.;
- De Pontville, M.;
- Saada-Bouzid, E.;
- Beylot-Barry, M.;
- Simon, C.;
- Jouary, T.;
- Marabelle, A.;
- Mortier, L.
Publication type:
Article
Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2687, doi. 10.1007/s00262-023-03448-w
By:
- Bordignon, María B.;
- Pesce Viglietti, Ayelén I.;
- Juliá, Estefanía P.;
- Sanchez, María B.;
- Rölle, Alexander;
- Mandó, Pablo;
- Sabatini, Luciana;
- Ostinelli, Alexis;
- Rizzo, Manglio M.;
- Barrio, María M.;
- Mordoh, José;
- Fainboim, Leonardo;
- Levy, Estrella M.
Publication type:
Article
Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2717, doi. 10.1007/s00262-023-03453-z
By:
- Inoue, Yusuke;
- Inui, Naoki;
- Karayama, Masato;
- Asada, Kazuhiro;
- Fujii, Masato;
- Matsuura, Shun;
- Uto, Tomohiro;
- Hashimoto, Dai;
- Matsui, Takashi;
- Ikeda, Masaki;
- Yasui, Hideki;
- Hozumi, Hironao;
- Suzuki, Yuzo;
- Furuhashi, Kazuki;
- Enomoto, Noriyuki;
- Fujisawa, Tomoyuki;
- Suda, Takafumi
Publication type:
Article
Self-assembled nanoparticles based on DNA origami and a nitrated T helper cell epitope as a platform for the development of personalized cancer vaccines.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2741, doi. 10.1007/s00262-023-03446-y
By:
- Kang, Yanliang;
- Zhang, Wanli;
- Yu, Qiumin;
- Gao, Le;
- Quan, Jiale;
- Gu, Fangling;
- Wu, Yuxin;
- Tian, Yahong;
- Wu, Zijie;
- Shao, Shishuai;
- Zhou, Hongyou;
- Duan, Shukang;
- Zhou, Yixiang;
- Zhang, Li;
- Gao, Xiangdong;
- Tian, Hong;
- Yao, Wenbing
Publication type:
Article
Nervous regulation: beta-2-adrenergic signaling in immune homeostasis, cancer immunotherapy, and autoimmune diseases.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2549, doi. 10.1007/s00262-023-03445-z
By:
- Thapa, Sagarina;
- Cao, Xuefang
Publication type:
Article
Cytotoxicity of CD19-CAR-NK92 cells is primarily mediated via perforin/granzyme pathway.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2573, doi. 10.1007/s00262-023-03443-1
By:
- Althaus, Jonas;
- Nilius-Eliliwi, Verena;
- Maghnouj, Abdelouahid;
- Döring, Sascha;
- Schroers, Roland;
- Hudecek, Michael;
- Hahn, Stephan A.;
- Mika, Thomas
Publication type:
Article
Engineered murine IL-21-secreting leukemia cells induce granzyme B+ T cells and CD4+CD44+CD62L− effector memory cells while suppressing regulatory T cells, leading to long-term survival.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2597, doi. 10.1007/s00262-023-03442-2
By:
- Berger, Alexandra;
- Colpitts, Sarah J.;
- Zych, Morgan;
- Paige, Christopher J.
Publication type:
Article
Identification of a novel immune checkpoint molecule V-set immunoglobulin domain-containing 4 that leads to impaired immunity infiltration in pancreatic ductal adenocarcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2701, doi. 10.1007/s00262-023-03438-y
By:
- Jiang, Yongsheng;
- Han, Lijie;
- Yang, Jian;
- Yang, Minwei;
- Zhang, Jian;
- Xue, Meilin;
- Zhu, Youwei;
- Xiong, Cheng;
- Shi, Minmin;
- Zhao, Shiwei;
- Shen, Baiyong;
- Xu, Zhiwei;
- Jiang, Lingxi;
- Chen, Hao
Publication type:
Article
Switchable CAR T cell strategy against osteosarcoma.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2623, doi. 10.1007/s00262-023-03437-z
By:
- Hidalgo, Laura;
- Somovilla-Crespo, Beatriz;
- Garcia-Rodriguez, Patricia;
- Morales-Molina, Alvaro;
- Rodriguez-Milla, Miguel Angel;
- Garcia-Castro, Javier
Publication type:
Article
Phase I study of MSB2311, a novel pH-dependent anti-PD-L1 monoclonal antibody, treating patients with advanced solid tumors and lymphoma.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2729, doi. 10.1007/s00262-023-03434-2
By:
- Zhang, Qi;
- Zhang, Jian;
- Zhong, Haijun;
- Yuan, Ying;
- Yang, Lei;
- Zhang, Qingyuan;
- Ji, Dongmei;
- Gong, Jifang;
- Li, Jing;
- Yao, Zhenling;
- Qi, Chuan;
- Wang, Jianming;
- Lu, Lingmin;
- Shi, Michael;
- Qian, Xueming;
- Shen, Lin;
- Li, Jian;
- Hu, Xichun
Publication type:
Article
Characteristic differences in the abundance of tumor-infiltrating lymphocytes and intratumoral developing T cells in thymoma, with special reference to PD-1 expression.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2585, doi. 10.1007/s00262-023-03431-5
By:
- Furuya, Tatsuo;
- Ishihara, Shunta;
- Ogi, Hiroshi;
- Masuda, Kyoko;
- Shibata, Saya;
- Nakazono, Chiaki;
- Okada, Satoru;
- Shimomura, Masanori;
- Tando, So;
- Yaoi, Takeshi;
- Maeda, Yoshinobu;
- Yamagishi, Masaaki;
- Kawamoto, Hiroshi;
- Itoh, Kyoko;
- Inoue, Masayoshi
Publication type:
Article
Incidence of serious adverse events caused by tyrosine kinase inhibitor treatment following immune checkpoint inhibitor therapy in advanced NSCLC patients with oncogenic driver alterations.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2613, doi. 10.1007/s00262-023-03429-z
By:
- Shimoda, Yukiko;
- Yoshida, Tatsuya;
- Miyakoshi, Jun;
- Torasawa, Masahiro;
- Tateishi, Akiko;
- Matsumoto, Yuji;
- Masuda, Ken;
- Shinno, Yuki;
- Okuma, Yusuke;
- Goto, Yasushi;
- Horinouchi, Hidehito;
- Yamamoto, Noboru;
- Ohe, Yuichiro
Publication type:
Article
BAP1-related signature predicts benefits from immunotherapy over VEGFR/mTOR inhibitors in ccRCC: a retrospective analysis of JAVELIN Renal 101 and checkmate-009/010/025 trials.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2557, doi. 10.1007/s00262-023-03424-4
By:
- Liu, Kan;
- Huang, Yan;
- Xu, Yu;
- Wang, Guoqiang;
- Cai, Shangli;
- Zhang, Xu;
- Shi, Taoping
Publication type:
Article
Correction to: IL‑17A promotes fatty acid uptake through the IL‑17A/IL‑17RA/ p‑STAT3/FABP4 axis to fuel ovarian cancer growth in an adipocyte‑rich microenvironment.
Published in:
2023
By:
- Yu, Chunyan;
- Niu, Xiulong;
- Du, Yongrui;
- Chen, Yan;
- Liu, Xiaomei;
- Xu, Lingling;
- Iwakura, Yoichiro;
- Ma, Xiaoxia;
- Li, Yan;
- Yao, Zhi;
- Deng, Weimin
Publication type:
Correction Notice
Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2865, doi. 10.1007/s00262-023-03432-4
By:
- Naoe, Tomoki;
- Saito, Akiko;
- Hosono, Nahoko;
- Kasahara, Senji;
- Muto, Hideharu;
- Hatano, Kaoru;
- Ogura, Mizuki;
- Masunari, Taro;
- Tanaka, Masatsugu;
- Usuki, Kensuke;
- Ishikawa, Yuichi;
- Ando, Koji;
- Kondo, Yukio;
- Takagi, Yusuke;
- Takada, Satoru;
- Ishikawa, Maho;
- Choi, Ilseung;
- Sano, Akihiro;
- Nagai, Hirokazu
Publication type:
Article

Works matching IS 03407004 AND DT 2023 AND VI 72 AND IP 8

Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors.

Induction of cancer neoantigens facilitates development of clinically relevant models for the study of pancreatic cancer immunobiology.

Enhanced HPV16 E6/E7<sup>+</sup> tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides.

Sequential CAR T cell and targeted alpha immunotherapy in disseminated multiple myeloma.

Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer.

Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12.

Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel developed from bulk mRNA sequencing and single-cell RNA-sequencing.

Correction to: Increased TIGIT expressing NK cells with dysfunctional phenotype in AML patients correlated with poor prognosis.

The pathogenetic significance of exhausted T cells in a mouse model of mature B cell neoplasms.

Single-center phase 2 study of PD-1 inhibitor combined with DNA hypomethylation agent + CAG regimen in patients with relapsed/refractory acute myeloid leukemia.

Massively recruited sTLR9<sup>+</sup> neutrophils in rapidly formed nodules at the site of tumor cell inoculation and their contribution to a pro-tumor microenvironment.

Characterizing the tumor immune microenvironment of ependymomas using targeted gene expression profiles and RNA sequencing.

Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas.

Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients.

Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy.

Self-assembled nanoparticles based on DNA origami and a nitrated T helper cell epitope as a platform for the development of personalized cancer vaccines.

Nervous regulation: beta-2-adrenergic signaling in immune homeostasis, cancer immunotherapy, and autoimmune diseases.

Cytotoxicity of CD19-CAR-NK92 cells is primarily mediated via perforin/granzyme pathway.

Engineered murine IL-21-secreting leukemia cells induce granzyme B<sup>+</sup> T cells and CD4<sup>+</sup>CD44<sup>+</sup>CD62L<sup>−</sup> effector memory cells while suppressing regulatory T cells, leading to long-term survival.

Identification of a novel immune checkpoint molecule V-set immunoglobulin domain-containing 4 that leads to impaired immunity infiltration in pancreatic ductal adenocarcinoma.

Switchable CAR T cell strategy against osteosarcoma.

Phase I study of MSB2311, a novel pH-dependent anti-PD-L1 monoclonal antibody, treating patients with advanced solid tumors and lymphoma.

Characteristic differences in the abundance of tumor-infiltrating lymphocytes and intratumoral developing T cells in thymoma, with special reference to PD-1 expression.

Incidence of serious adverse events caused by tyrosine kinase inhibitor treatment following immune checkpoint inhibitor therapy in advanced NSCLC patients with oncogenic driver alterations.

BAP1-related signature predicts benefits from immunotherapy over VEGFR/mTOR inhibitors in ccRCC: a retrospective analysis of JAVELIN Renal 101 and checkmate-009/010/025 trials.

Correction to: IL‑17A promotes fatty acid uptake through the IL‑17A/IL‑17RA/ p‑STAT3/FABP4 axis to fuel ovarian cancer growth in an adipocyte‑rich microenvironment.

Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide.